Impact of cyclosporine‐based immunosuppressive therapy on liver histology of hepatitis C virus–infected renal transplant patients
Open Access
- 20 June 2008
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 48 (1), 348-349
- https://doi.org/10.1002/hep.22331
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5BHepatology, 2007
- The Hepatitis C Virus Life Cycle as a Target for New Antiviral TherapiesGastroenterology, 2007
- A Cyclosporine-Based Immunosuppressive Regimen May Be Better Than Tacrolimus for Long-Term Liver Allograft Survival in Recipients Transplanted for Hepatitis CTransplantation Proceedings, 2006
- Long-Term Outcomes in Liver Transplant Patients With Hepatic C Infection Receiving Tacrolimus or CyclosporineTransplantation Proceedings, 2006
- Suppression of Hepatitis C Virus Replication by Cyclosporin A Is Mediated by Blockade of CyclophilinsGastroenterology, 2005
- Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patientsClinical Transplantation, 2005
- Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytesHepatology, 2003
- Hepatitis C virus infection and renal transplantationAmerican Journal of Kidney Diseases, 2001